KMT2A and cervical cancer: In summary, our study has demonstrated that KMT2A regulates cervical cancer cell growth via targeting VDAC1 signaling, indicating that the KMT2A/VADC1 signaling axis may be a new mechanism of cervical tumorigenesis and a potential therapeutic target for cervical cancer treatment.